Navigation Links
BIO-key(R) Reports First Quarter 2010 Financial Results
Date:5/13/2010

WALL, N.J., May 13 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions, today reported financial results for the first quarter ended March 31, 2010. For clarity and consistency, the data presented in this release includes only the results of the Company's fingerprint-based Biometrics Division for such period.  The Company completed the sale of its Law Enforcement Division on December 8, 2009.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO)

2010 First Quarter Consolidated Results

Total revenue for the three months ended March 31, 2010 was $976,175 representing an increase of 81% from the $538,194 reported for the quarter ended March 31, 2009. 

BIO-key's gross margin for the first quarter of 2010 was 89.0% compared to 75% for the same period in 2009.  Operating expenses for the first quarter of 2010 were reduced by 13% to $984,809 compared to expenses of $1,128,729 in the quarter ended March 31, 2009.  First quarter 2010 operating loss was $118,734, significantly improved from an operating loss of $727,614 in the first quarter of 2009. Accounting for income from derivative and warrant fair value adjustments and income from discontinued op
'/>"/>

SOURCE BIO-key International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology news :

1. BIO-key(R) International Invited to Speak at Annual SafeTrace(R) User Group Meeting
2. BIO-key(R) Delivers FBI-Compliant 2 Factor Authentication Solution for First Responders
3. BIO-key(R) International Taps JMR Worldwide for PR, IR and Strategic Communications
4. BIO-key(R) International Biometric Accuracy Improved by More Than 23% as Reported in Recent NIST Testing
5. BIO-key(R) International to Showcase Biometric Identification Technology at RSA Conference 2010
6. BIO-key(R) Launches TruDonor ID(TM), the First SaaS (Software as a Service) Biometric Identification Solution
7. BIO-key(R) Broadens Biometric Support for Microsoft(R) Windows Terminal Services, Citrix(R) Clients and Wyse CE Terminals
8. BIO-key(R) Appoints Cecilia Welch as Chief Financial Officer
9. BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division
10. BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine
11. BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 5% and 10% of breast and ovarian cancers are ... tumours are attributable to inherited mutations from the parents ... with these mutations, PARP inhibitors, which are currently in ... a new option for personalised cancer treatment, an alternative ... a fraction of these patients generate resistance to the ...
(Date:6/18/2013)... of internationally recognized feline experts including veterinarians and feline ... of Lincoln, U.K. and Dr Ilona Rodan, Director of ... International Society of Feline Medicine (ISFM) and the American ... veterinarians, owners and those working with cats on how ... The new guidelines appear in the Journal of ...
(Date:6/17/2013)... to high levels of air pollution while pregnant were up ... as women who lived in areas with low pollution, according ... (HSPH). It is the first large national study to examine ... "Our findings raise concerns since, depending on the pollutant, 20% ... areas where risk of autism was elevated," said lead author ...
Breaking Biology News(10 mins):An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Feline behavior experts release guidelines to improve the welfare of cats 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
... Mont. -- Natural barriers like waterfalls play an important ... National Park, so maintaining those barriers should be a ... four-year study in the park. Park workers might ... the water from rising behind those barriers, said graduate ...
... more than 300 leading European and Chinese scientists have ... in the Peoples Republic of China to present their ... Dragon 2. The Dragon Programme is a joint ... Technology (MOST) of China designed to encourage increased exploitation ...
... (April 24, 2008) The Wildlife Conservation Society (WCS) ... change is affecting populations of a quintessential Arctic denizen: ... the National Park Service, U. S. Geological Survey, and ... already equipped six musk ox with GPS collars to ...
Cached Biology News:Montana State researchers study spread of lake trout in Glacier National Park 2Successful cooperation extends Dragon Program 2Successful cooperation extends Dragon Program 3
(Date:6/19/2013)... India , June 19, ... Bharat Book Bureau presents Innovative ... and Formulation Technology Licensing Opportunities ... http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html ) There ... or controlled release drugs approved ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of ... it has received Class III medical device license approval ... DrugCheck® NxStep Onsite Drug Screen Cup in Canada. ... device in near-patient settings, such as physicians’ offices. , ... Canada Class III approval for 24 different drugs and ...
(Date:6/18/2013)... In support of Swiss contributions to scientific ... Switzerland in New York is pleased to welcome the ... , to Manhattan. PlanetSolar is in New York ... with scientists on board from the University of Geneva. ... on energy from the sun and eliminates the need ...
(Date:6/18/2013)... DuPont welcomes 48 of the nation’s ... National AgriScience Teachers Ambassador Academy this week (NATAA) at ... , The NATAA “Ag Academy” is a ... special project of the National FFA Foundation ... . The highly recommended agriscience teachers, who are ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3
... German . , Automation makes a business competitive ... small and medium-sized enterprises (SMEs). However, for many SMEs, ... too big or too expensive. SMErobot now promises to ... in small and medium-sized businesses: this EU project is ...
... 28 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc.,(NASDAQ: AEZS ... on,endocrine therapy and oncology, will announce its fourth ... market open on,Wednesday, March 5, 2008. The Company ... these results later that same day at 10:00 ...
... KOSN ) today reported financial results for the,quarter and year ... and year ended December 31, 2007 were $9.5,million and $28.7 ... and $29.5 million, or $0.13 and $0.88 per share, in ... million and $22.7 million for the quarter and year,ended December ...
Cached Biology Technology:SMErobot: A new generation of robots for small and medium-sized enterprises at Automatica 2008 2SMErobot: A new generation of robots for small and medium-sized enterprises at Automatica 2008 3SMErobot: A new generation of robots for small and medium-sized enterprises at Automatica 2008 4Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 2Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 3Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 4Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 5Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook 6
Human MFRP MAb (Clone 291218)...
Human RELT/TNFRSF19L MAb (Clone 238104)...
...
... assay kit measures NOS activity by monitoring ... This assay is simple, sensitive, and specific ... with both crude and purified enzyme preparations. ... for 50 total reactions. Radiolabeled arginine and ...
Biology Products: